Caribou Biosciences Inc. (NASDAQ: CRBU): Oppenheimer reiterated its Outperform rating with a $36 target price. The consensus target is $29.43. The shares were crushed Monday, down a sharp 26%, despite posting solid clinical data last Friday.

Coinbase Global Inc. (NASDAQ: COIN): J.P. Morgan downgraded the cryptocurrency brokerage to Neutral from Overweight and slashed the $171 price target to $68. The consensus target is $149.17. The stock closed almost 12% lower on Monday at $52.01.

Covetrus Inc. (NASDAQ: CVET): Stifel cut its Buy rating to Hold with a $22 target price. The consensus target is $21.33. The stock closed on Monday at $20.67.

Dell Technologies Inc. (NYSE: DELL): The Zacks Bull of the Day stock has seen Wall Street positively revising quarterly estimates, says the analyst. Shares last closed at $47.25, and the consensus target price is $60.06.

Editas Medicine Inc. (NASDAQ: EDIT): Goldman Sachs maintained a Sell rating and has an $8 target price. The consensus target is $32.23 for now. Monday’s $10.00 close was down over 10% on the day.

Fidelity National Information Services Inc (NYSE: FIS): Evercore ISI’s upgrade to Outperform from In Line included a price target boost to $135 from $115. The consensus target is $132.88. The final trade for Monday was reported at $94.96.

Generac Holdings Inc. (NYSE: GNRC): Baird reiterated an Outperform rating with a $298 target price. That compares with a $386.65 consensus target and the final print on Monday at $244.52.

Hannon Armstrong Sustainable Infrastructure Capital Inc. (NYSE: HASI) Oppenheimer maintained an Outperform rating and has a $62 target price. The consensus target is $59.13. The shares ended Monday down almost 9% to $34.88.

Invesco Ltd. (NYSE: IVZ): BMO Capital Markets downgraded shares of the investment giant to Market Perform from Outperform and cut the $25 price target to $20. Monday’s closing trade was reported at $15.93, down close to 8% for the day, after hitting a 52-week low of $15.82 earlier in the day.

Kontoor Brands Inc. (NYSE: KTB): Goldman Sachs downgraded the stock to Neutral from Buy and lowered the price target to $34. The consensus target is $51.57. The shares were last seen Monday at $34.00.

Magellan Midstream Partners L.P. (NYSE: MMP): Goldman Sachs raised its Neutral rating to Buy with a $59 target price. The consensus target is $54.53. The stock closed at $51.61 on Monday.

Marathon Petroleum Corp. (NYSE: MPC): BMO Capital Markets started coverage with an Outperform rating and a $135 target price. The consensus target is $117.08. The stock closed on Monday at $102.17.